Unlock instant, AI-driven research and patent intelligence for your innovation.

Reversibly immortalized hepatocytes and methods of use

a technology of hepatocytes and immortalized cells, which is applied in the field of liver disease and hepatic failure treatment, can solve the problems of human livers, increase the risk of malignant transformation, and severely limit the use of this method for liver failure treatmen

Inactive Publication Date: 2007-11-15
FOX IRA J +2
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0012] Another aspect of the invention provides a method of making a population of functional hepatocytes for transplantation into a patient, which comprises: (a) providing a sample of primary hepatocytes; (b) immortalizing the hepatocytes by transforming the hepatocytes with a vector comprising a removable DNA construct containing an oncogene, a selectable marker gene, and a gene encoding herpes simplex virus thymidine kinase, the genes together being flanked on either s

Problems solved by technology

The shortage of human livers available as a source of hepatocytes for transplantation severely limits the use of this method for the treatment of liver failure.
However, the continued presence of the oncogene (encoding SV40Tag) in these cells is of concern, inasmuch as it may increase the risk of malignant transformation following transplantation.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Reversibly immortalized hepatocytes and methods of use
  • Reversibly immortalized hepatocytes and methods of use
  • Reversibly immortalized hepatocytes and methods of use

Examples

Experimental program
Comparison scheme
Effect test

example 1

Reversible Immortalization of Rat Primary Hepatocytes Using the Cre / Lox System

[0069] In the protocols described in this example, rat primary hepatocytes were immortalized using a recombinant Moloney-based retrovirus containing the gene encoding SV40Tag flanked by loxP sites. Cells were characterized before and after treatment with a recombinant adenovirus capable of transferring the gene encoding the Cre-recombinase to determine whether this approach could produce an hepatocyte cell line that would be useful clinically for transplantation.

Materials and Methods

[0070] Animals. Inbred male Lewis rats (150-250 g) were obtained from Harlan Sprague-Dawley (Indianapolis, Ind.) and maintained in the Animal Resource Facility of the University of Nebraska College of Medicine (Omaha, Nebr.). Animals were maintained on standard laboratory chow on a 12-hour light / dark cycle. Severe combined immunodeficiency (SCID) mice were purchased from the Jackson Laboratory (Bar Harbor, Me.) and maintaine...

example 2

In Vivo Characteristics and Function of loxP / Cre Generated Reversibly Immortalized Rat Hepatocytes

[0097] The functional capacity of 24 individual hepatocyte cell clones that secreted albumin into the culture media was then assessed in an experimental model of inducible hepatic encephalopathy. Total portacaval shunts (PCS) were performed on Lewis rats that were then subjected to ammonium acetate administration. PCS rats that receive exogenous ammonium acetate become hyperammonemic and comatose within 30 minutes (Conjeevaram et al, Hepatology 19: 1245-1250, 1994; Ribiero et al., Hepatology 15:12-18, 1992; Blei et al., Hepatology 19: 1437-1443, 1994). Encephalopathy can also be quantified by means of a coma scale based on evaluation of a variety of behavioral reflexes (Maximum: 15 points indicates normal behavior) (Rigotti et al., Arch Surg. 120: 1290-1295).

[0098] Two weeks after PCS, 3×107 cells from each clone, including C8-B cells, were transplanted by injection into the inferior ...

example 3

Reversibly Immortalized Rat Hepatocyte Transplantation Enhances Liver Function and Survival in Cirrhotic Rats

[0107] Hepatocyte transplantation was shown to be effective in treating liver failure in cirrhotic rats. A determination was made as to whether reversibly immortalized hepatocytes could improve liver function and survival in a model of liver failure physiologically identical to that seen clinically.

[0108] Development of a reproducible model of end-stage liver disease secondary to cirrhosis in rats. None of the classic rodent models for acute liver failure or encephalopathy directly correlate with the physiologic abnormalities associated with the chronic liver dysfunction that is seen in patients. In order to address the role of hepatocyte transplantation in treating decompensated chronic liver disease, liver cirrhosis was induced in rats using phenobarbital (Sigma Chem. Co. St. Louis, Mo.) and carbon tetrachloride (CCl4, Sigma). Lewis rats were given phenobarbital (0.5 g / L)...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Electrical resistanceaaaaaaaaaa
Login to View More

Abstract

Hepatocyte cells that are reversibly immortalized and grown in culture, which are functional and safe for use in transplantation, are disclosed. Also disclosed are methods for immortalizing primary hepatocytes, expanding the population of immortalized hepatocytes in culture, then reversing the immortalization to produce hepatocytes that are functional and safe for use in transplantation.

Description

[0001] This application claims priority to U.S. Provisional Application No. 60 / 101,812, filed Sep. 25, 1998, and to copending PCT Application No. PCT / US99 / 22207 filed Sep. 24, 1999, each of which is incorporated by reference herein in its entirety.[0002] Pursuant to 35 U.S.C. §202(c), it is acknowledged that the U.S. Government has certain rights in the invention described herein, which was made in part with funds from the National Institutes of Health, Grant Nos. R01-AI 31641 and DK48794-01.FIELD OF THE INVENTION [0003] This invention relates to the treatment of liver disease and hepatic failure. In particular, the invention provides hepatocyte cells reversibly immortalized and grown in culture, which are functional and safe for use in transplantation. BACKGROUND OF THE INVENTION [0004] Several scientific publications and patent documents are referenced in this patent application to describe the state of the art to which the invention pertains. Each of these publications is incorpo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K48/00A61K39/00A61P1/16C12N5/08C12N5/071
CPCA61K35/12C12N5/067C12N9/00C12N2800/30C12N2510/04C12N2799/022C12N2799/027C12N9/1211A61P1/16
Inventor FOX, IRA J.LEBOULCH, PHILIPPEKOBAYASHI, NAOYA
Owner FOX IRA J